Akero Therapeutics, Inc. - Common Stock (AKRO)

Historical Holders from Q2 2019 to Q1 2025

Symbol
AKRO on Nasdaq
CUSIP
00973Y108
Type / Class
Equity / Common Stock
Shares outstanding
69.4M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
74.2M
Holdings value
$2.06B
% of all portfolios
0.005%
Grand Portfolio weight change
0%
Number of holders
190
Number of buys
92
Number of sells
-67
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Akero Therapeutics, Inc. - Common Stock (AKRO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 9.8% $315M 6.86M RTW Investments, LP Dec 31, 2024
JANUS HENDERSON GROUP PLC 8.7% $277M 6.03M JANUS HENDERSON GROUP PLC Dec 31, 2024

Institutional Holders of Akero Therapeutics, Inc. - Common Stock (AKRO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 1.57M $63.5M +$22.8M $40.48 10
2024 Q4 74.2M $2.06B -$8.51M $27.82 190
2024 Q3 73M $2.09B +$38.3M $28.69 170
2024 Q2 71.8M $1.68B -$32.5M $23.46 152
2024 Q1 73.1M $1.85B +$381M $25.26 172
2023 Q4 58.4M $1.36B -$172M $23.35 151
2023 Q3 56.8M $2.87B +$62.9M $50.58 177
2023 Q2 56.2M $2.63B +$390M $46.69 154
2023 Q1 48M $1.84B -$63.2M $38.26 153
2022 Q4 48.5M $2.66B +$143M $54.80 155
2022 Q3 46.4M $1.58B +$488M $34.05 138
2022 Q2 34.7M $328M -$12M $9.45 102
2022 Q1 35M $496M -$4.32M $14.19 95
2021 Q4 35.2M $744M +$3.82M $21.15 92
2021 Q3 28M $626M +$6.66M $22.35 102
2021 Q2 25.7M $638M -$131M $24.81 94
2021 Q1 31.5M $913M +$20.6M $29.01 108
2020 Q4 30.8M $813M +$45.3M $25.80 92
2020 Q3 29M $892M +$220M $30.79 102
2020 Q2 21.8M $544M -$5.68M $24.92 75
2020 Q1 21.7M $460M +$62.8M $21.20 65
2019 Q4 19M $422M +$18.2M $22.19 57
2019 Q3 12.7M $288M +$54.8M $22.75 54
2019 Q2 10.7M $205M +$205M $19.15 48